Suppr超能文献

己烯雌酚诱导雄性大鼠催乳素分泌型垂体瘤的时间进程:结节漏斗多巴胺能神经元的反应

Time course of induction of prolactin-secreting pituitary tumors with diethylstilbestrol in male rats: response of tuberoinfundibular dopaminergic neurons.

作者信息

Morgan W W, Steger R W, Smith M S, Bartke A, Sweeney C A

出版信息

Endocrinology. 1985 Jan;116(1):17-24. doi: 10.1210/endo-116-1-17.

Abstract

3,4-Dihydroxyphenylalanine (Dopa) accumulation and dopamine (DA) and noradrenaline levels were measured in the median eminence (ME) of Fisher 344-derived inbred male rats. These animals had been treated with Silastic capsules containing 8-9 mg diethylstilbestrol (DES) or with empty capsules for 3, 7, 14, or 30 days and had the pellets removed 22 days before killing. In an additional group of rats, the DES pellets were continuously present until killing. Blood was collected before treatment was started, at pellet removal, 2 days before killing, and at killing. All rats received 50 mg/kg hydroxybenzylhydrazine (NSD-1015), an L-aromatic amino acid decarboxylase inhibitor, iv 30 min before killing, and the subsequent accumulation of Dopa provided an indirect measure of DA synthesis. Treatment with DES for 7, 14, or 30 days produced an elevation of circulating PRL. Although this elevation of PRL levels was substantially reduced after pellet removal, this parameter was still elevated in the 30-day DES-treated rats at the time of killing. Pituitary levels of PRL and PRL secretion in vitro were elevated in both the 14- and the 30-day DES-treated rats. Rats treated continuously with DES had markedly elevated circulating PRL levels, and the pituitary content and in vitro release of this hormone were also enhanced. DA synthesis, as evidenced by the accumulation of Dopa after NSD-1015 treatment, was significantly elevated in the ME of rats treated with DES for 14 or 30 days while the concentration of DA was reduced in the 30-day treated rats. DA synthesis in the ME was not different from controls in rats treated continuously with DES, although DA levels were markedly suppressed. Pituitary weights were elevated, and BWs were reduced in rats continuously treated with DES. Pituitary weights were also elevated in rats treated with DES for 30 days although not as much as in rats treated continuously with DES. A progressive reduction in seminal vesicles and testes weights was observed with longer periods of DES treatment. Testosterone levels were suppressed in rats treated continuously with DES. In a second study in which rats received DES pellets for 2 months and then the pellets were removed for 4 months, 1 mg bromocriptine sc markedly suppressed the elevated levels of circulating PRL. Collectively, these results show that 14 to 30 days of DES treatment are sufficient to induce PRL-secreting adenohypophysial tumors in adult male rats, although considerable involution of the tumor appears to occur after pellet removal.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在源自Fisher 344的近交系雄性大鼠的正中隆起(ME)中测量了3,4 - 二羟基苯丙氨酸(多巴)的积累以及多巴胺(DA)和去甲肾上腺素的水平。这些动物用含有8 - 9毫克己烯雌酚(DES)的硅橡胶胶囊或空胶囊处理3、7、14或30天,并在处死前22天取出药粒。在另一组大鼠中,DES药粒一直保留到处死。在开始治疗前、取出药粒时、处死前2天和处死时采集血液。所有大鼠在处死前30分钟静脉注射50毫克/千克羟基苄基肼(NSD - 1015),一种L - 芳香族氨基酸脱羧酶抑制剂,多巴随后的积累提供了DA合成的间接测量指标。用DES治疗7、14或30天导致循环中催乳素(PRL)升高。尽管取出药粒后PRL水平的这种升高大幅降低,但在处死时,30天DES治疗组大鼠的该参数仍升高。在14天和30天DES治疗组大鼠中,垂体PRL水平和体外PRL分泌均升高。持续用DES治疗的大鼠循环中PRL水平显著升高,该激素的垂体含量和体外释放也增强。NSD - 1015治疗后多巴的积累证明,用DES治疗14或30天的大鼠ME中DA合成显著升高,而在30天治疗组大鼠中DA浓度降低。持续用DES治疗的大鼠ME中DA合成与对照组无差异,尽管DA水平明显受到抑制。持续用DES治疗的大鼠垂体重量增加,体重减轻。用DES治疗30天的大鼠垂体重量也增加,尽管不如持续用DES治疗的大鼠增加得多。随着DES治疗时间延长,观察到精囊和睾丸重量逐渐减轻。持续用DES治疗的大鼠睾酮水平受到抑制。在第二项研究中,大鼠接受DES药粒2个月,然后取出药粒4个月,皮下注射1毫克溴隐亭显著抑制了循环中升高的PRL水平。总体而言,这些结果表明,14至30天的DES治疗足以在成年雄性大鼠中诱导分泌PRL的腺垂体肿瘤,尽管取出药粒后肿瘤似乎有相当程度的退化。(摘要截取自400字)

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验